Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-12-13
2000-11-21
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514805, 530399, A61K 3800
Patent
active
061503304
ABSTRACT:
Prolonged parenteral release into the circulatory system of a cow of a bioactive growth hormone releasing factor at desirably effective levels can be achieved using novel compositions in which the growth hormone releasing factor is present in an aqueous liquid at a dose of at least about 50 mg and at a concentration of at least about 20 mg/ml. Preferably, the growth hormone releasing factor is present in an aqueous liquid at a dose of about 200 mg and at a concentration of about 180 mg/ml. The aqueous bovine somatotropin formulation provides for the sustained release of bovine somatotropin into the circulatory system of the animal for greater than seven (7) days.
REFERENCES:
patent: 4977140 (1990-12-01), Ferguson
patent: 5013713 (1991-05-01), Mitchell
patent: 5352662 (1994-10-01), Brooks
patent: 5756458 (1998-05-01), Kubiak et al.
Tucker et al., J. Dairy Sci., 78:1489-1497, (1995).
Dahl et al., J. Dairy Sci., 77:2518-2525, (1994).
Pitt, C.G.; "The controlled parental delivery of polypeptides and proteins"; International Journal of Pharmaceutics, vol. 59, pp. 173-196 (1990).
Mariette, Be atrice; "Release of the GRF29NH.sub.2 analog of human GRF44NH.sub.2 from a PLA/GA matrix"; Journal of Controlled Release, vol. 24, pp. 237-246 (1993).
Carmona, P.; "Structural study of human growth hormone-releasing factor fragment (1-29) by vibrational spectroscopy"; Spectrochimica Acta, vol. 51A, No. 5, pp. 929-938 (1995).
Caputo James F.
Foster Todd P.
Hageman Michael J.
Moseley William M.
Cintins Marianne M.
Delacroix-Muirheid C.
Pharmacia & Upjohn Company
Rehberg Edward F.
LandOfFree
Aqueous prolonged release formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous prolonged release formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous prolonged release formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257188